In vitro enzymatic processing of radiolabelled big ET-1 in human kidney

Biochemical Pharmacology

Volumn 55, Issue 5, 1998, Pages 697-701

  Russell, Fraser D ^a   Coppell, Alexander L ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endothelin; Endothelin converting enzyme; Human kidney

Indexed keywords

BIG ENDOTHELIN 1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY; MALE; PRIORITY JOURNAL; PROTEIN PROCESSING;

AGED; ASPARTIC ENDOPEPTIDASES; ENDOTHELIN-1; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; KIDNEY CORTEX; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; NEPRILYSIN; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0032032214     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00515-7     Document Type: Article

References (19)

1. 1. Shimada K, Takahashi M and Tanzawa K, Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 269: 18275-18278, 1994.
2. 2. Valdenaire O, Rohrbacher E and Mattei M-G, Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 270: 29794-29798, 1995.
3. 3. Murphy LJ, Corder R, Mallet AI and Turner AJ, Generation by the phosphoramidon-sensitive peptidases, endopeptidase-24.11 and thermolysin, of endothelin-1 and C-terminal fragment from big endothelin-1. Br J Pharmacol 113: 137-142, 1994.
4. 4. Turner AJ and Murphy LJ, Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51: 91-102, 1996.
5. 5. Huggins JP, Pelton JT and Miller RC, The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol Ther 39: 55-123, 1993.
6. 6. Simonson MS, Endothelins: multifunctional renal peptides. Physiol Rev 73: 375-411, 1993.
7. 7. Takada J, Hata M, Okada K, Matsuyama K and Yano M, Biochemical properties of endothelin converting enzyme in renal epithelial cell lines. Biochem Biophys Res Commun 182: 1383-1388, 1992.
8. 8. Ahlborg G, Ottosson-Seeberger A, Hemsén A and Lundberg JM, Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure. Cardiovasc Res 28: 1559-1563, 1994.
9. 9. Hemsén A, Ahlborg G, Ottosson-Seeberger A and Lundberg JM, Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Reg Peptides 55: 287-297, 1995.
10. 10. Plumpton C, Kalinka S, Martin RC, Horton JK and Davenport AP, Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays. Clin Sci 87: 245-251, 1994.
11. B selective ligands in human and rat heart. Br J Pharmacol 119: 631-636, 1996.
12. 12. Russell FD, Skepper JN and Davenport AP, Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J Cardiovasc Pharmacol 29: 820-826, 1997.
13. 13. McPherson GA, A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed 17: 107-113, 1983.
14. 14. Munson PJ and Rodbard D, Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239, 1980.
15. 15. Ohlstein EH, Beck GR, Douglas SA, Nambi P, Lago MA, Gleason JG, Ruffolo RR, Feuerstein G and Elliott JD, Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J Pharmacol Exp Ther 271: 762-768, 1994.
16. B in human kidney. Kid Int 44: 36-42, 1993.
17. 17. Cernacek P, Legault L, Stewart DJ and Levy M, Specific endothelin binding sites in renal medullary collecting duct cells: lack of interaction with ANP binding and cGMP signalling. Can J Physiol Pharmacol 70: 1167-1174, 1992.
18. 18. Lopez-Farre A, Gomez-Garre D, Bernabeu F and Lopez-Novoa JM, A role for endothelin in the maintenance of post-ischaemic renal failure in the rat. J Physiol 444: 513-555, 1991.
19. 19. Vemulapalli S, Chiu PJS, Chintala M and Bernardino V, Attenuation of ischemic acute renal failure by phosphoramidon in rats. Pharmacology 47: 188-193, 1993.